Close

RBC Capital Reiterates Sector Perform on Darden Restaurants (DRI) Following 1Q Report

Go back to RBC Capital Reiterates Sector Perform on Darden Restaurants (DRI) Following 1Q Report

Oppenheimer Reiterates Outperform on Darden Restaurants (DRI) Following 1Q Report

October 5, 2016 9:51 AM EDT

Oppenheimer reiterated an Outperform rating and $70.00 price target on Darden Restaurants (NYSE: DRI) following the company's 1Q earnings report. DRI reported EPS of $0.88, ahead of the Street's $0.82 estimate. Management raised F17E EPS guidance to $3.87-$3.97 (was $3.80-$3.90), vs. Street's $3.87.

Analyst Brian Bittner... More

Options with increasing volume: MTDR BRCD VNO

October 4, 2016 9:47 AM EDT

Options with increasing volume: MTDR BRCD VNO DRI BRCD NEM DAL NFLX HPE SDRL ETSY AAL NBR DOV BLDP TGP MUX

... More

Pre-Open Stock Movers 10/04: (SMMT) (SDRL) (ARLZ) Higher; (TRIB) (IRMD) (TWTR) Lower (more...)

October 4, 2016 9:22 AM EDT

Today's Pre-Open Stock Movers

Summit Therapeutics plc (Nasdaq: SMMT) 80% HIGHER; Sarepta Therapeutics (Nasdaq: SRPT) and Summit Therapeutics plc (Nasdaq: SMMT) announced that they have entered into an exclusive license and collaboration agreement granting Sarepta rights in Europe, as well as in Turkey and the Commonwealth of Independent States (the licensed territory), to Summits utrophin modulator pipeline, including its lead clinical candidate, ezutromid, for the treatment of Duchenne muscular dystrophy (DMD). As part of the agreement, Sarepta also obtains an option... More

Darden Restaurants (DRI) Tops Q1 EPS by 6c; Boosts FY17 EPS Outlook; $500M Stock Buyback Approved

October 4, 2016 7:06 AM EDT

Darden Restaurants (NYSE: DRI) reported Q1 EPS of $0.88, $0.06 better than the analyst estimate of $0.82. Revenue for the quarter came in at $1.71 billion versus the consensus estimate of $1.72 billion.

Same-restaurant sales increased 1.3% for the quarter.

Stock Buyback News:

During the... More